Anti-BCMA CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-BCMA CAR-T cells, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma [Phase 1]